Aditya Birla Sun Life Pharma & Healthcare Fund
The fund maintains heavy conviction in large-cap pharma dominance, with Sun Pharma anchoring over a third of assets and the top five names representing nearly 35 percent of the portfolio. The concentrated 77 percent pharma allocation reflects a classic defensive positioning around domestic generics and export-driven stories, while the modest healthcare services exposure provides modest diversification within the thematic. The addition of Dr. Lal Path Labs and trimming of IPCA signals the manager's preference for diagnostics upside over mid-tier generic makers facing margin pressures.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Regular Growth | ₹33.4900 | +8.66% | +12.57% | +24.85% | +13.25% |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| Dr. Lal Path Labs Limited | 0.94% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited INE044A01036 | 13.17% |
| 2 | Apollo Hospitals Enterprise Limited INE437A01024 | 7.20% |
| 3 | Torrent Pharmaceuticals Limited INE685A01028 | 4.76% |
| 4 | J.B. Chemicals & Pharmaceuticals Limited INE572A01036 | 4.71% |
| 5 | Aurobindo Pharma Limited INE406A01037 | 4.49% |
| 6 | Ajanta Pharmaceuticals Limited INE031B01049 | 4.05% |
| 7 | Lupin Limited INE326A01037 | 4.00% |
| 8 | Mankind Pharma Ltd INE634S01028 | 3.88% |
| 9 | Fortis Healthcare Limited INE061F01013 | 3.87% |
| 10 | Abbott India Limited INE358A01014 | 3.65% |
| 11 | Emcure Pharmaceuticals Ltd INE168P01015 | 3.32% |
| 12 | Cipla Limited INE059A01026 | 3.30% |
| 13 | IPCA Laboratories Limited INE571A01038 | 2.86% |
| 14 | Shilpa Medicare Ltd INE790G01031 | 2.51% |
| 15 | CORONA Remedies Ltd INE02ZQ01018 | 2.24% |
| 16 | SAI Life Sciences Ltd INE570L01029 | 2.20% |
| 17 | Alkem Laboratories Limited INE540L01014 | 2.10% |
| 18 | Procter & Gamble Health Limited INE199A01012 | 2.04% |
| 19 | Divi's Laboratories Limited INE361B01024 | 1.88% |
| 20 | Jupiter Life Line Hospitals Ltd INE682M01012 | 1.79% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does Aditya Birla Sun Life Pharma & Healthcare Fund hold?
Aditya Birla Sun Life Pharma & Healthcare Fund holds 39 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 34.33% of NAV.
What is the largest holding in Aditya Birla Sun Life Pharma & Healthcare Fund?
The largest position in Aditya Birla Sun Life Pharma & Healthcare Fund is Sun Pharmaceutical Industries Limited, accounting for 13.17% of NAV in the Pharmaceuticals & Biotechnology sector.
Is Aditya Birla Sun Life Pharma & Healthcare Fund a concentrated or diversified fund?
With a Gini coefficient of 0.394, Aditya Birla Sun Life Pharma & Healthcare Fund is well-diversified. The HHI concentration index is 45,462 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 34.33% of the portfolio.
What is the market cap allocation of Aditya Birla Sun Life Pharma & Healthcare Fund?
Based on SEBI's AMFI classification, Aditya Birla Sun Life Pharma & Healthcare Fund's equity portfolio is split as: Large Cap: 32.53%, Mid Cap: 27.98%, Small Cap: 38.09%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does Aditya Birla Sun Life Pharma & Healthcare Fund invest in most?
Aditya Birla Sun Life Pharma & Healthcare Fund has the highest allocation to Pharmaceuticals & Biotechnology (77.31%), Healthcare Services (19.60%), nan (1.39%). The fund is invested across 5 sectors in total.
How actively managed is Aditya Birla Sun Life Pharma & Healthcare Fund compared to other Sectoral / Thematic funds?
Aditya Birla Sun Life Pharma & Healthcare Fund has an Active Share of 90.10%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.
What changed in Aditya Birla Sun Life Pharma & Healthcare Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, Aditya Birla Sun Life Pharma & Healthcare Fund added 1 new stock (including Dr. Lal Path Labs Limited). Total holding count increased from 39 to 40 stocks.